Status:
COMPLETED
Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol
Lead Sponsor:
Meir Medical Center
Conditions:
Infertility
Eligibility:
FEMALE
Up to 38 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if pretreatment with Estrogen can assist in the planning and programming of In Vitro Fertilization treatments.
Detailed Description
A randomised controlled trial in which study group will be given estrogen derivative before ovarian stimulation in GnRH antagonist protocol and compared to the classical GnRH agonist protocol.Estrogen...
Eligibility Criteria
Inclusion
- IVF treatment in the following indications: Male, Mechanical, Unexplained
- Age\<38 years
- Treatment Cycle number 1-4
Exclusion
- Ovulatory disorder as an indication for IVF
- Repeated failure in previous IVF treatments (\> than 4 cycles)
- Sperm used for treatment was retrieved by surgical procedure
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT01419353
Start Date
August 1 2011
End Date
June 1 2013
Last Update
December 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel, Israel